Dengue NS1 vs IgM/IgG Rapid Tests
Direct answer: NS1 antigen detects the dengue virus itself and is most useful in the first week of fever; IgM/IgG antibodies detect the immune response and become more reliable from about day 5 onward. A combined NS1 + IgM/IgG device covers the widest diagnostic window in a single test.
Comparison table
| NS1 Antigen | IgM/IgG Antibody | |
|---|---|---|
| What it detects | Viral NS1 protein (active virus) | Immune response to infection |
| First detectable | Day 1 of fever | IgM ~day 3–5; IgG later |
| Best window | First week (early acute) | Late acute / convalescent |
| Specimen | Whole blood / serum / plasma | Whole blood / serum / plasma |
| What it tells you | Active infection | Exposure / past or secondary infection |
| Key caveat | Serotype-dependent sensitivity | Flavivirus cross-reactivity (e.g., Zika) |
What each method detects
- NS1 antigen is a non-structural protein secreted during viral replication — a direct marker of the virus, so a positive result reflects active infection.
- IgM/IgG antibodies are the host's immune response — a positive result reflects exposure, which can be a current, recent or past infection.
Testing window
NS1 is typically detectable from day 1 of fever through the first week. IgM appears around day 3–5 and IgG later. Outside the first week, serology (IgM/IgG) becomes the more useful marker.
Strengths
- NS1: earliest detection, active-infection signal, fewer false positives from past infection.
- IgM/IgG: useful after the first week, supports primary-vs-secondary interpretation (IgG pattern).
Limitations
- NS1: sensitivity varies by serotype; may be negative later in the illness.
- IgM/IgG: cross-reactivity with other flaviviruses (Zika, yellow fever, Japanese encephalitis); antibody timing limits early detection.
False negative / positive considerations
- False negatives: testing outside the marker's window (NS1 too late, IgM too early); low viral load.
- False positives: flavivirus cross-reactivity (IgM/IgG); prior vaccination or past dengue (IgG).
Confirmatory testing
Rapid tests are screening-grade. Where confirmation is required, RT-PCR (RNA detection) is the reference, or paired serology on acute and convalescent samples.
Procurement considerations
- For distributors: a combined NS1 + IgM/IgG device reduces SKU count and covers the full window.
- For tropical field programs: room-temperature-stable, instrument-free formats are preferred.
Related products
Which test to choose
Choose NS1 for early presentation (≤7 days of fever); choose IgM/IgG for later or convalescent presentation; choose a combined NS1+IgM/IgG device when timing is unknown — it covers the widest window in one test.
Last reviewed: 2026-09-12